The acute-phase response in (NZB X NZW)F1 and MRL/l MICE

doi:10.1084/jem.156.4.1268

This Article

	Full Text (PDF, 341K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Rordorf, C.
	Articles by Pepys, M. B.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Rordorf, C.
	Articles by Pepys, M. B.


Social Bookmarking

	What's this?

ARTICLES

The acute-phase response in (NZB X NZW)F1 and MRL/l MICE

C Rordorf, HP Schnebli, ML Baltz, GA Tennent and MB Pepys

The acute-phase plasma protein response to disease activity in murine models of autoimmune lupus-like disease was investigated by measurement of the concentration of serum amyloid P component (SAP) in NZB X W and MRL/l mice. The levels of SAP, which is a major acute-phase protein in mice, did not rise at all in response to progression of disease in NZB X W mice between the ages of 1 and 9 mo. This resembles the behavior of acute-phase proteins such as C-reactive protein and serum amyloid A protein in human systemic lupus erythematosus, and just as in human lupus, where the occurrence of intercurrent microbial infection can stimulate an acute-phase response, so injection of bacterial lipopolysaccharide or casein into the NZB X W mice stimulated "normal" acute-phase SAP production. In marked contrast, MRL/l mice developed greatly increased levels of SAP, which correlated closely with progression of their pathology as they aged. The disease profile of the MRL/l strain includes rheumatoid factors and spontaneous polyarthritis and their SAP response resembles the behavior of acute phase proteins in human rheumatoid arthritis. Different patterns of acute-phase response in different autoimmune disorders may thus be a reflection of the genetic predisposition to particular diseases and/or contribute to their pathogenesis. The existence of animal counterparts for the various clinical patterns of human acute-phase protein production will assist in experimental investigation of the underlying mechanisms and of the biological role of the acute-phase response.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Edberg, J. C., Wu, J., Langefeld, C. D., Brown, E. E., Marion, M. C., McGwin, G. Jr, Petri, M., Ramsey-Goldman, R., Reveille, J. D., Frank, S. G., Kaufman, K. M., Harley, J. B., Alarcon, G. S., Kimberly, R. P. (2008). Genetic variation in the CRP promoter: association with systemic lupus erythematosus. Hum Mol Genet 17: 1147-1155 [Abstract] [Full Text]
Baruah, P., Propato, A., Dumitriu, I. E., Rovere-Querini, P., Russo, V., Fontana, R., Accapezzato, D., Peri, G., Mantovani, A., Barnaba, V., Manfredi, A. A. (2006). The pattern recognition receptor PTX3 is recruited at the synapse between dying and dendritic cells, and edits the cross-presentation of self, viral, and tumor antigens. Blood 107: 151-158 [Abstract] [Full Text]
Russell, A. I., Cunninghame Graham, D. S., Shepherd, C., Roberton, C. A., Whittaker, J., Meeks, J., Powell, R. J., Isenberg, D. A., Walport, M. J., Vyse, T. J. (2004). Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet 13: 137-147 [Abstract] [Full Text]
Lawman, S, Ehrenstein, M R (2002). Many paths lead to lupus. Lupus 11: 801-806
Gershov, D., Kim, S., Brot, N., Elkon, K. B. (2000). C-Reactive Protein Binds to Apoptotic Cells, Protects the Cells from Assembly of the Terminal Complement Components, and Sustains an Antiinflammatory Innate Immune Response: Implications for Systemic Autoimmunity. JEM 192: 1353-1364 [Abstract] [Full Text]